Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gene Logic, Abbott Enter Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Gene Logic, Abbott Enter Discovery Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Gene Logic, Inc. has entered into an agreement with Abbott to discover additional development paths for several of Abbott’s drug candidates, all of which have successfully completed Phase I trials.

Under the agreement, Gene Logic is eligible to receive success-based milestone payments for each drug candidate Abbott returns to clinical development. Gene Logic will also receive royalties for each drug candidate that is marketed. Gene Logic has the option to receive an exclusive license to any drug candidate that Abbott chooses not to pursue, in which case Abbott will receive success-based milestone and royalty payments. Financial terms of the agreement were not disclosed.

Gene Logic’s Drug Repositioning Program seeks to find alternative indications for high-quality drug candidates with good safety records that have been de-prioritized or discontinued in clinical trials.

Charles L. Dimmler, III, Gene Logic’s chief executive officer and president said, “We are delighted that Abbott chose Gene Logic as its partner to find new development paths for their drug candidates. Our program is designed to provide a comprehensive picture of the drug candidates’ biological activities and determine if there are new therapeutic uses for these potential medicines.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics